1. Home
  2. PSTV vs MHUA Comparison

PSTV vs MHUA Comparison

Compare PSTV & MHUA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTV
  • MHUA
  • Stock Information
  • Founded
  • PSTV 1996
  • MHUA 1990
  • Country
  • PSTV United States
  • MHUA China
  • Employees
  • PSTV N/A
  • MHUA N/A
  • Industry
  • PSTV Medical/Dental Instruments
  • MHUA Medical Specialities
  • Sector
  • PSTV Health Care
  • MHUA Health Care
  • Exchange
  • PSTV Nasdaq
  • MHUA Nasdaq
  • Market Cap
  • PSTV 17.0M
  • MHUA 19.6M
  • IPO Year
  • PSTV N/A
  • MHUA 2022
  • Fundamental
  • Price
  • PSTV $0.37
  • MHUA $0.42
  • Analyst Decision
  • PSTV Strong Buy
  • MHUA
  • Analyst Count
  • PSTV 3
  • MHUA 0
  • Target Price
  • PSTV $10.83
  • MHUA N/A
  • AVG Volume (30 Days)
  • PSTV 65.2M
  • MHUA 102.1K
  • Earning Date
  • PSTV 08-13-2025
  • MHUA 04-25-2025
  • Dividend Yield
  • PSTV N/A
  • MHUA N/A
  • EPS Growth
  • PSTV N/A
  • MHUA N/A
  • EPS
  • PSTV N/A
  • MHUA 0.40
  • Revenue
  • PSTV $5,206,000.00
  • MHUA $96,909,642.00
  • Revenue This Year
  • PSTV $14.10
  • MHUA N/A
  • Revenue Next Year
  • PSTV $7.96
  • MHUA N/A
  • P/E Ratio
  • PSTV N/A
  • MHUA $1.08
  • Revenue Growth
  • PSTV N/A
  • MHUA N/A
  • 52 Week Low
  • PSTV $0.16
  • MHUA $0.25
  • 52 Week High
  • PSTV $2.31
  • MHUA $1.47
  • Technical
  • Relative Strength Index (RSI)
  • PSTV 52.77
  • MHUA 48.82
  • Support Level
  • PSTV $0.27
  • MHUA $0.41
  • Resistance Level
  • PSTV $0.38
  • MHUA $0.51
  • Average True Range (ATR)
  • PSTV 0.03
  • MHUA 0.05
  • MACD
  • PSTV 0.01
  • MHUA -0.00
  • Stochastic Oscillator
  • PSTV 81.82
  • MHUA 41.35

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

About MHUA Meihua International Medical Technologies Co. Ltd.

Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.

Share on Social Networks: